Flat Is The New Up As Biogen Anticipates Stabilizing Product Revenue In 2024

EPS Will Rise, Primarily Due To Cost Cuts

 
• By Mandy Jackson
  
Biogen sign at its headquarters in Cambridge, Massachusetts
Biogen expects lower total revenue and flat product revenue in 2024 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip